Fine Foods & Pharmaceuticals N.T.M Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Fine Foods & Pharmaceuticals N.T.M heeft een totaal eigen vermogen van €130.5M en een totale schuld van €56.4M, wat de schuld-eigenvermogensverhouding op 43.2% brengt. De totale activa en totale passiva bedragen respectievelijk €232.0M en €101.4M. De EBIT Fine Foods & Pharmaceuticals N.T.M is €15.2M waardoor de rentedekking 4.7 is. Het heeft contanten en kortetermijnbeleggingen van €9.1M.

Belangrijke informatie

43.2%

Verhouding schuld/eigen vermogen

€56.44m

Schuld

Rente dekkingsratio	4.7x
Contant	€9.06m
Aandelen	€130.55m
Totaal verplichtingen	€101.41m
Totaal activa	€231.96m

Recente financiële gezondheidsupdates

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Dec 08

Recent updates

Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business

Sep 20

Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Apr 28

Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Mar 20

Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

Feb 22

A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

Feb 01

What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

Jan 14

We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Dec 28

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Dec 08

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €91.7M ) FF } overtreffen de korte termijn passiva ( €62.3M ).

Langlopende schulden: De kortetermijnactiva FF ( €91.7M ) overtreffen de langetermijnschulden ( €39.2M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 36.3% ) FF wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van FF is de afgelopen 5 jaar gestegen van 21.1% naar 43.2%.

Schuldendekking: De schuld van FF wordt goed gedekt door de operationele kasstroom ( 74.1% ).

Rentedekking: De rentebetalingen op de schuld van FF worden goed gedekt door EBIT ( 4.7 x dekking).

Fine Foods & Pharmaceuticals N.T.M Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Recent updates

Third quarter 2024 earnings released

New major risk - Revenue and earnings growth

Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business

Second quarter 2024 earnings released

Now 20% undervalued

Upcoming dividend of €0.12 per share

First quarter 2024 earnings released

Now 20% undervalued after recent price drop

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2023 earnings released

Second quarter 2023 earnings released

New major risk - Revenue and earnings growth

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) commences an Equity Buyback Plan for 20% of its issued share capital,under the authorization approved on May 9, 2023.

First quarter 2023 earnings released

Upcoming dividend of €0.10 per share at 1.3% yield

Less than half of directors are independent

Consensus forecasts updated

Price target decreased to €11.50

Second quarter 2022 earnings released

First quarter 2022 earnings: Revenues in line with analyst expectations

Upcoming dividend of €0.16 per share

Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Price target decreased to €14.25

Less than half of directors are independent

Full year 2021 earnings: EPS misses analyst expectations

Now 30% undervalued after recent price drop

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) made an offer to acquire an additional 24.94% stake in Euro Cosmetic Spa (BIT:EC) for €10.2 million.

Price target decreased to €20.50

Third quarter 2021 earnings released

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) signed a binding agreement to acquire a 72.9% stake in Euro Cosmetic S.p.A. (BIT:EC) from Findea's Srl and MD S.R.L. for €26.8 million.

First half 2021 earnings released: €0.26 loss per share

Price target increased to €18.50

Upcoming dividend of €0.14 per share

Full year 2020 earnings released: EPS €0.58 (vs €0.12 loss in FY 2019)

Price target increased to €15.50

Price target increased to €14.90

Consensus EPS estimates fall to €0.52

Full year 2020 earnings released: EPS €0.58 (vs €0.34 in FY 2019)

Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Fine Foods & Pharmaceuticals N.T.M. S.p.A. to Report Fiscal Year 2020 Results on Apr 12, 2021

Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Price target raised to €13.50

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

New 90-day high: €11.30

New 90-day low: €9.76

First half earnings released

New 90-day low: €10.45

New 90-day high - €11.10

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven